| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $6.23M | $5.70M | – | – | – |
| SG&A | $4.86M | $4.20M | $5.71M | $7.14M | $2.50M |
| Operating Income | -$11.09M | -$9.90M | -$13.30M | -$13.55M | -$5.59M |
| Interest Expense | – | – | $2.21M | $45.00K | $1.19M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$11.13M | -$10.21M | -$11.28M | -$12.34M | -$4.04M |
| EPS (basic) | -0.4400 | -0.5400 | -0.8300 | -1.0700 | -0.6500 |
| EPS (diluted) | -0.4400 | -0.5400 | -0.8300 | -1.0700 | – |
| Shares (diluted) | $25.48M | $18.60M | – | – | – |